Original article
Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: A placebo-controlled study

https://doi.org/10.1016/S0022-3999(96)00265-6Get rights and content

Abstract

There is conflicting evidence regarding the effects of hormone replacement therapy (HRT) with estrogens on psychological and psychiatric symptoms of menopause. Forty women already attending a menopause clinic for continuing HRT by estrogen implants were studied in a randomized, double-blind, placebo-controlled study of estrogen reimplantation versus implantation of a placebo preparation. Assessment included self rating with visual analog scales, standardized psychological and menopause rating scales (Hospital Anxiety and Depression Scale, Self-Concept Questionnaire, Cognitive Failures Questionnaire, Greene Menopause Index), and interview with the Present State Examination. No difference in outcome with regard to either psychological or psychiatric symptoms was found 2 months after entry to the study between the women who received an active implant and those who received a placebo implant, in spite of the former group having a significant rise in estradiol levels. The only effect of HRT on physical symptoms was a nonsignificant reduction in flushes. Psychiatric morbidity of the study population was high with nearly half being “psychiatric cases” according to the Present State Examination at both initial assessment and follow-up. At entry to the study nearly all the women had levels of estradiol in the premenopausal range and four had supraphysiological levels. It appears likely that women were returning requesting a new implant because of symptoms related to nonhormonal factors. Women receiving continuing HRT for menopausal symptoms should be reassessed both for hormonal status and current psychosocial factors when they present with recurrent symptoms, especially those of a psychological or psychiatric nature.

References (25)

  • S Campbell

    Double blind psychometric studies on the effects of natural oestrogens on postmenopausal women

  • P. Belchetz

    Hormone replacement treatment

    BMJ

    (1989)
  • Cited by (45)

    • Sex differences in the blood–brain barrier: Implications for mental health

      2022, Frontiers in Neuroendocrinology
      Citation Excerpt :

      In vitro studies and surgical approaches such as OVX have yielded important discoveries that helped to better understand estrogen-mediated modulation of BBB integrity; however, they fail to replicate the natural cycling levels of gonadal hormones. Thus, these findings may not translate readily to mental health research in humans, which is probably why estrogen replacement therapy has shown mixed results in human cohorts (Pearce et al., 1997; Weiser et al., 2019). Another major limitation of these studies in the context of mental disorder research is the lack of investigation for behavioral endpoints.

    • Urinary phytoestrogens and depression in perimenopausal US women: NHANES 2005-2008

      2014, Journal of Affective Disorders
      Citation Excerpt :

      There is some evidence that hormone therapy (HT) improves psychological well-being of menopausal women (Haines et al., 2003). Soares et al. found that the transdermal oestradiol therapy had a significant antidepressant effect in perimenopausal women, whereas Pearce et al. observed that HT did not affect depression or anxiety (Pearce et al., 1997; Soares et al., 2001). To prevent potential medical risks associated with the use of HT, it may be of interest to evaluate the effect of natural estrogens such as phytoestrogens on the risk of depression in perimenopausal women.

    • The Menopause: A Signal for the Future

      2007, Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, Third Edition
    View all citing articles on Scopus
    View full text